BiPAD®, LLC has completed the research and development of the BiPAD® hand-activated electrocautery device. After more then fifty iterations using advanced CAD/CAM and 3D printing technologies, the company has concluded development and is now focused on manufacturing and regulatory issues, says CEO Dr. Louis G. Cornacchia.
"This device will have a tremendous impact on surgeries in almost every specialty world-wide while decreasing surgeon fatigue, cost of surgery and blood loss. I believe that this simple yet elegant device is transformative",
said Dr. Philp Stieg, Chairman of Neurosurgery a Cornell Medical Center and an investor in the device.
BiPAD®, LLC expects to bring the device to market by early 2020.